Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

174
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

206
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
206
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

186
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
186
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

152
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
152
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

295
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
295
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

604
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
604

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heart Disease in Children: Heart Murmurs.

FP essentials·2025
Same author

Heart Disease in Children: Cardiac Preparticipation Evaluation.

FP essentials·2025
Same author

Heart Disease in Children: Cardiac Dysrhythmias.

FP essentials·2025
Same author

Heart Disease in Children: Inflammatory Syndromes.

FP essentials·2025
Same author

Acute Coronary Syndrome: Presentation and Diagnostic Evaluation.

FP essentials·2020
Same author

Respiratory Conditions: Upper Respiratory Tract Infections.

FP essentials·2019

Related Experiment Video

Updated: Dec 26, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.6K

Acute Coronary Syndrome: Postdischarge Care.

Craig Barstow1

  • 1Womack Army Medical Center, 2817 Reilly Road, Fort Bragg, NC 28310-73010.

FP Essentials
|March 10, 2020
PubMed
Summary

Prompt follow-up care after acute coronary syndrome is crucial for therapy adherence and reducing readmissions. Early office visits and care coordinator support improve outcomes for cardiac patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Preventive Cardiology

Background:

  • Acute coronary syndrome (ACS) requires diligent post-discharge management to prevent complications.
  • Delayed follow-up care (beyond 6 weeks) is linked to reduced patient adherence to prescribed therapies.
  • Care coordinator involvement has demonstrated positive impacts on readmission and mortality rates.

Purpose of the Study:

  • To outline optimal post-discharge care strategies for patients following an acute coronary syndrome.
  • To emphasize the importance of timely follow-up and adherence to medical therapy.
  • To provide guidance on medication management, lifestyle modifications, and further cardiac evaluations.

Main Methods:

  • Review of current guidelines and evidence for post-ACS care.

More Related Videos

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

463
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.5K

Related Experiment Videos

Last Updated: Dec 26, 2025

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.6K
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

463
Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

28.5K
  • Focus on pharmacological management including statins, antiplatelet agents, anticoagulants, beta-blockers, and ACE inhibitors.
  • Emphasis on lifestyle interventions such as smoking cessation and cardiac rehabilitation.
  • Guidance on timing and necessity of further diagnostic testing (stress tests, imaging).

    • Main Results:

    • Early post-discharge follow-up (within 6 weeks) is associated with better adherence.
    • High-intensity statins, dual antiplatelet therapy (for at least 12 months post-stent), and beta-blockers are key components of therapy.
    • Low-dose rivaroxaban may be considered for select patients, and ACE inhibitors are recommended for those with low LVEF.
    • Smoking cessation and cardiac rehabilitation significantly improve patient outcomes.

    Conclusions:

    • Optimized post-discharge care, including timely follow-up and adherence to evidence-based therapies, is critical for ACS survivors.
    • Comprehensive management should address cardiovascular risk factors, medication regimens, and lifestyle changes.
    • Individualized treatment plans, guided by clinical status and LVEF, are essential for long-term patient health and recovery.